Share this article The approval date for Eli Lilly’s donanemab has been pushed from the previously expected time in 1Q 2024 to a date as
Acadia Pharmaceuticals said Monday that its approved medicine called Nuplazid failed to improve the social and emotional symptoms of schizophrenia in a late-stage clinical trial.
A Newcastle research team has been exploring the role of vitamin A in the pathogenesis of psychiatric disorders.
Prostate cancer stands as a prevalent threat to men’s health, ranking second in cancer-related deaths in the United States.
A blood test that can accurately detect when someone has not slept for 24 hours has been developed by experts at Monash University, in Australia,
Hundreds of messages from an internal chat board for an international group of transgender health professionals were leaked in a think tank report last week
New study indicates that mushroom extract might demonstrate superior efficacy compared to chemically synthesized psilocybin, especially in stimulating neuroplasticity and promoting the development of new
The University of Houston College of Pharmacy is included in a $68.5 million funding package from the Cancer Prevention and Research Institute of Texas (CPRIT).
A team of investigators from the UCLA Health Jonsson Comprehensive Cancer and the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute
Share this article On 8 March, at the AD/PD 2024 International Conference on Alzheimer’s and Parkinson’s Diseases, during a symposium titled “Therapeutic Intervention in AD